Patents : |  |
| US Patent No. | Title |
| 7597886 | Tumor necrosis factor-gamma
|
| 7601724 | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
| 7601745 | Heterocyclic NF-kB inhibitors
|
| 7604799 | EphA4 Antibodies
|
| 7604947 | Detection and modulation of cancer stem cells
|
| 7605149 | Modulation of the phospholipase A2 pathway as a therapeutic
|
| 7605155 | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
| 7605175 | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
| 7605236 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein
|
| 7605241 | Synthesis of inhibitors of p90Rsk
|
| 7605266 | Azaindole inhibitors of Aurora kinases
|
| 7601716 | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
| 7601700 | Modulation of eIF4E expression
|
| 7601694 | CLK-peptide and SLK-peptide
|
| 7598049 | Methods for diagnosis of Alzheimer's Disease in blood samples
|
| 7598232 | Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
|
| 7598239 | Conjugated psychotropic drugs and uses thereof
|
| 7598345 | Immunostimulatory compositions and methods
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7598355 | Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
|
| 7599745 | Treating a tumor or the like with an electric field
|
| 7601355 | Compositions and methods for altering immune function
|
| 7601359 | Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
|
| 7601496 | Cleavage of nucleic acids
|
| 7608260 | Stabilized immunoglobulins
|
| 7608392 | Diagnostic assay for measuring a cell mediated immune response
|
| 7615208 | Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging
|
| 7615209 | Compositions of NDV and methods of use thereof for treatment of cancer
|
| 7615570 | Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
| 7615632 | Crystalline forms of temozolomide
|
| 7618637 | Heat shock protein-based vaccines and immunotherapies
|
| 7618939 | Compositions and methods to prevent cancer with cupredoxins
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618975 | 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7618982 | Heteroarylpyrrolopyridinones active as kinase inhibitors
|
| 7612202 | Process for preparing temozolomide
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612162 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7608612 | Radiosensitizer formulations and methods for use
|
| 7608634 | Substituted pyrrolines as kinase inhibitors
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7611910 | Method for diagnosis of alzheimer's disease
|
| 7612039 | Method of cell growth inhibition with agnoprotein
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
